LLY

998.88

-0.19%↓

JNJ

243.11

-0.23%↓

ABBV

227.62

+0.42%↑

NVS

155.44

-3.77%↓

AZN

192.99

-1.1%↓

LLY

998.88

-0.19%↓

JNJ

243.11

-0.23%↓

ABBV

227.62

+0.42%↑

NVS

155.44

-3.77%↓

AZN

192.99

-1.1%↓

LLY

998.88

-0.19%↓

JNJ

243.11

-0.23%↓

ABBV

227.62

+0.42%↑

NVS

155.44

-3.77%↓

AZN

192.99

-1.1%↓

LLY

998.88

-0.19%↓

JNJ

243.11

-0.23%↓

ABBV

227.62

+0.42%↑

NVS

155.44

-3.77%↓

AZN

192.99

-1.1%↓

LLY

998.88

-0.19%↓

JNJ

243.11

-0.23%↓

ABBV

227.62

+0.42%↑

NVS

155.44

-3.77%↓

AZN

192.99

-1.1%↓

Home・Aandelen Lijst・Celldex Therapeutics Inc

Celldex Therapeutics Inc

Gesloten

SectorGezondheidszorg

31.22 0.87

Buy Sell

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

30.48

Max

31.63

Belangrijke statistieken
By Trading Economics
Inkomsten	-14M -81M
Verkoop	75K 75K
EPS	-1.22
Winstmarge	-108,422.667
Werknemers	198
EBITDA	-7.8M -81M

Aanbevelingen
By TipRanks
Aanbevelingen	Buy
12 Maanden Prognose	+76.24% upside

Dividenden
By Dow Jones
Volgende Winsten	6 mei 2026

Marktinformatie
By TradingEconomics
Marktkapitalisatie	430M 2B
Vorige openingsprijs	30.35
Vorige sluitingsprijs	31.22

Technische score

By Trading Central

Vertrouwen

Weak Bullish Evidence

18.91 / 20.63 Steun & Weerstand

Celldex Therapeutics Inc Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

11 mrt 2026, 19:18 UTC

Belangrijke Marktbewegers

Stryker Shares Down After Cyberattack Tied to Iran-Linked Group

11 mrt 2026, 23:54 UTC

Marktinformatie

Global Forex and Fixed Income Roundup: Market Talk

11 mrt 2026, 23:54 UTC

Marktinformatie

Nikkei May Decline on Energy Costs Concerns -- Market Talk

11 mrt 2026, 23:51 UTC

Marktinformatie

Gold Falls as Rising Oil Prices Spur Inflation Worries -- Market Talk

11 mrt 2026, 23:41 UTC

Marktinformatie

REA Bull Sees Potential Upside to Yield Guidance -- Market Talk

11 mrt 2026, 23:37 UTC

Marktinformatie

Belangrijke Nieuwsgebeurtenissen

Oil Futures Rise Amid Ongoing Middle East Conflict -- Market Talk

11 mrt 2026, 23:17 UTC

Belangrijke Nieuwsgebeurtenissen

Front-Month WTI Crude Oil Futures Rise 5.5% to $92.05/bbl

11 mrt 2026, 23:17 UTC

Belangrijke Nieuwsgebeurtenissen

Front-Month Crude Oil Futures Rise Amid Ongoing Middle East Conflict

11 mrt 2026, 22:29 UTC

Marktinformatie

Australia Shares Set to Fall in Early Trade -- Market Talk

11 mrt 2026, 21:47 UTC

Winsten

Liontown Resources: Market Tailwinds Strengthening Outlook

11 mrt 2026, 21:46 UTC

Winsten

Liontown Resources: 4 Mln Ton Per Annum Expansion Study Underway

11 mrt 2026, 21:45 UTC

Winsten

Liontown Resources Says FY26 Guidance Unchanged

11 mrt 2026, 21:45 UTC

Winsten

Liontown Resources 1H Unit Operating Costs A$985/Ton

11 mrt 2026, 21:44 UTC

Winsten

Liontown Resources 1H Underlying Ebitda Loss A$7.7 Million

11 mrt 2026, 21:43 UTC

Winsten

Liontown Resources 1H Revenue A$207.5 Million

11 mrt 2026, 21:43 UTC

Winsten

Liontown Resources 1H Net Loss A$184 Million

11 mrt 2026, 21:12 UTC

Acquisities, Fusies, Overnames

Netflix Rival Strikes Deal With Google in Battle for AI Content -- Barrons.com

11 mrt 2026, 21:10 UTC

Winsten

Vista Gold FY25 Loss $7.5M >VGZ

11 mrt 2026, 21:10 UTC

Winsten

Vista Gold FY25 Loss/Shr 6c >VGZ

11 mrt 2026, 20:50 UTC

Marktinformatie

Belangrijke Nieuwsgebeurtenissen

Basic Materials Roundup: Market Talk

11 mrt 2026, 20:50 UTC

Marktinformatie

Health Care Roundup: Market Talk

11 mrt 2026, 20:27 UTC

Acquisities, Fusies, Overnames

Papa John's Draws Fresh Takeover Interest -- 2nd Update

11 mrt 2026, 20:26 UTC

Winsten

These Stocks Are Today's Movers: Oracle, UniFirst, Fair Isaac, Nebius, AeroVironment, Campbell's, and More -- Barrons.com

11 mrt 2026, 20:19 UTC

Belangrijke Nieuwsgebeurtenissen

The Strait of Hormuz Could Take Weeks -- Even Months -- to Reopen, Military Experts Say -- Barrons.com

11 mrt 2026, 20:15 UTC

Winsten

This Physical AI Stock Jumped on Earnings. The Robots Are Coming. -- Barrons.com

11 mrt 2026, 20:12 UTC

Belangrijke Nieuwsgebeurtenissen

Stock Market Today: Oil Prices Push Higher Despite IEA Oil Release Headline -- WSJ

11 mrt 2026, 19:31 UTC

Marktinformatie

Belangrijke Nieuwsgebeurtenissen

Oil Futures Gain Despite IEA's Planned Release of Reserves -- Market Talk

11 mrt 2026, 19:01 UTC

Marktinformatie

Belangrijke Nieuwsgebeurtenissen

U.S. Natural Gas Gains With Middle East Conflict in View -- Market Talk

11 mrt 2026, 18:59 UTC

Acquisities, Fusies, Overnames

Berkshire's Deal for Occidental Chemicals Unit Is a Winner as Chemical Stocks Surge -- Barrons.com

11 mrt 2026, 18:43 UTC

Belangrijke Nieuwsgebeurtenissen

Chubb Named Lead Insurer for U.S. Plan to Protect Oil Tankers in Strait of Hormuz -- Barrons.com

Peer Vergelijking

Prijswijziging

Celldex Therapeutics Inc Prognose

Koersdoel

By TipRanks

76.24% opwaarts potentieel

12 Maanden Prognose

Gemiddelde 54.9 USD 76.24%

Hoogste 90 USD

Laagste 24 USD

Gebaseerd op 11 Wall Street-analisten die 12-maands prijsdoelen bieden voor Celldex Therapeutics Inc - Dist. in de afgelopen 3 maanden.

Beoordelingsconsensus

By TipRanks

Buy

11 ratings

Buy

Hold

Sell

Gebaseerd op 11 analisten die aandelenratings hebben gegeven aan Celldex Therapeutics Inc - Dist in de afgelopen 3 maanden.

Technische score

By Trading Central

18.91 / 20.63Steun & Weerstand

Recent bullish events outweigh bearish events.

All events are bearish.

Financieel

Verkoop- en administratiekosten

Bedrijfskosten

Winst voor belastingen

Verkoop

Kosten van verkopen

Brutowinst op verkopen

Rente-uitgaven op schulden

EBITDA

Operationele winst

Over Celldex Therapeutics Inc

Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. Its drug candidates include antibody-based therapeutics to treat patients with inflammatory, allergic, autoimmune, and other devastating diseases. The company's clinical development programs CDX-0159, a Phase II monoclonal antibody that binds the receptor tyrosine kinase KIT and inhibits its activity. It has research collaboration and license agreements with Yale University. The company was incorporated in 1983 and is headquartered in Hampton, New Jersey.